Qingqing Yi's most recent trade in BeiGene Ltd - ADR was a trade of 235 American Depositary Shares done at an average price of $279.1 . Disclosure was reported to the exchange on June 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BeiGene Ltd (ADR) | Qingqing Yi | Director | Sale of securities on an exchange or to another person at price $ 279.13 per share. | 01 Jun 2026 | 235 | 0 (0%) | 0% | 279.1 | 65,596 | American Depositary Shares |
| BeiGene Ltd (ADR) | Qingqing Yi | Director | Other type of transaction at price $ 0.00 per share. | 10 Jun 2025 | 29,614 | 27,326 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Qingqing Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 22,750 | 22,750 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Qingqing Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 10,985 | 56,940 (0%) | 0% | 0 | Ordinary Shares | |
| BeiGene Ltd (ADR) | Qingqing Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 34,151 | 34,151 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd (ADR) | Qingqing Yi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 16,341 | 45,955 (0%) | 0% | 0 | Ordinary Shares |